Biomarkers That Matter: The Molecular Signals Guiding Oncology Treatment
Published on: 01/10/2026
Discover how molecular biomarkers such as HER2, KRAS, and PD-L1 are helping guide treatment selection, clinical trials, and personalized cancer care.
Precision OncologyCancer BiomarkersMolecular BiomarkersBiomarker TestingPersonalized Cancer Treatment



